Publications
49
Citations
739
Est. group size
—
Recurring co-author estimate
Active years
18
Publishing since 2009
Patrice N. Mimche studies liver disease, focusing on how chronic liver injury progresses to fibrosis (scarring), fatty liver disease (MASH/steatohepatitis), and liver cancer. The work examines cellular signaling pathways—such as Eph/ephrin receptors and mitochondrial processes like cardiolipin and the electron transport chain—that drive tissue damage and could be targeted with new therapies. Related projects extend to fibrosis in other organs, cancer biology, and epigenetics.
Publication activity has fluctuated year to year but remained steady overall, averaging about four to five papers per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
Current awards run through July 2027 — about under a year of funding on record from today. Awards are often renewed, so this is what is currently public, not a forecast.
EphB/EphrinB signaling in Systemic Sclerosis
Small molecule antagonists targeting EphB receptors for the treatment of nonalcoholic steatohepatitis (NASH)
Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.
Typically publishes in teams of ~10 · 3% small-team papers (≤3 authors) · across 24 venues
- Excessive Ca <sup>2+</sup> -dependent ER-mitochondrial contact stabilization by EFHD1 drives liver injury
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- Author response: Cardiolipin deficiency disrupts electron transport chain and drives steatohepatitis
2026
- Cardiolipin deficiency disrupts electron transport chain and drives steatohepatitis
eLife · 2026
- Joint Public Review: Cardiolipin deficiency disrupts electron transport chain and drives steatohepatitis
2026
- TERC lncRNA in situ detection is useful in confirming cervical intraepithelial neoplasia in women with discordant histo-cytology diagnosis
Research Square · 2026
- Diet-induced MASH liver fibrosis promoted by EphB2 can be targeted by small molecule tetramerization inhibitors
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Erratum: HAF prevents hepatocyte apoptosis and progression to MASH and HCC through transcriptional regulation of the NF-κB pathway
Hepatology · 2025
- Cardiolipin deficiency disrupts electron transport chain and drives steatohepatitis
eLife · 2025
- Cardiolipin deficiency disrupts electron transport chain to drive steatohepatitis
eLife · 2025
- HAF prevents hepatocyte apoptosis and progression to MASH and HCC through transcriptional regulation of the NF-κB pathway
Hepatology · 2024
- EphB2 Signaling Is Implicated in Astrocyte-Mediated Parvalbumin Inhibitory Synapse Development
Journal of Neuroscience · 2024
- Role of epigenetic in cancer biology, in hematologic malignancies and in anticancer therapy
Frontiers in Molecular Medicine · 2024
- EphB2 Receptor Promotes Dermal Fibrosis in Systemic Sclerosis
Arthritis & Rheumatology · 2024
- Potential contribution of liver sinusoidal endothelial cell expressing EphrinB1 in fibrogenesis during metabolic dysfunction-associated steatohepatitis in mice
Physiology · 2024
- Cardiolipin deficiency disrupts electron transport chain and drives steatohepatitis
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- The Journal of Immunology×4
- bioRxiv (Cold Spring Harbor Laboratory)×4
- Figshare×4
- eLife×3
- Hepatology×2
- Andrea L. Conroy
Medicine · Indiana University
- Abebe A. Fola
Medicine · Purdue University West Lafayette
- Akshay S. Kulkarni
Medicine · Purdue University West Lafayette
- Aminata Fofana
Medicine · The Ohio State University
- Anna Chen
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 27, 2026.
Claim or correct this profile